DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $45,485,630 | +126348872.2% | 183,335 | -59.0% | 0.24% | +5825.0% |
| Q2 2023 | $36 | -99.9% | 446,810 | +340.3% | 0.00% | -98.2% |
| Q4 2022 | $27,901 | -99.9% | 101,487 | +0.4% | 0.22% | +1.4% |
| Q3 2022 | $25,431,000 | -7.7% | 101,046 | -6.2% | 0.21% | -5.3% |
| Q2 2022 | $27,541,000 | -8.2% | 107,686 | +0.7% | 0.23% | +3.7% |
| Q1 2022 | $29,986,000 | +2.7% | 106,948 | -0.7% | 0.22% | +1.4% |
| Q4 2021 | $29,211,000 | -15.9% | 107,711 | -2.8% | 0.22% | +2.9% |
| Q3 2021 | $34,726,000 | -25.0% | 110,810 | -23.5% | 0.21% | -24.3% |
| Q2 2021 | $46,304,000 | +12.4% | 144,793 | -8.7% | 0.28% | +12.2% |
| Q1 2021 | $41,207,000 | +4.7% | 158,624 | -4.0% | 0.25% | -1.6% |
| Q4 2020 | $39,346,000 | -2.6% | 165,291 | -4.8% | 0.25% | -14.7% |
| Q3 2020 | $40,381,000 | +18.4% | 173,564 | -0.4% | 0.29% | +11.4% |
| Q2 2020 | $34,097,000 | +32.6% | 174,312 | +11.9% | 0.26% | +11.4% |
| Q1 2020 | $25,718,000 | -1.5% | 155,800 | +0.9% | 0.24% | +19.2% |
| Q4 2019 | $26,116,000 | +20.8% | 154,486 | -2.5% | 0.20% | +15.8% |
| Q3 2019 | $21,626,000 | -1.3% | 158,507 | +1.0% | 0.17% | -2.8% |
| Q2 2019 | $21,920,000 | +2.0% | 156,966 | -4.0% | 0.18% | +1.1% |
| Q1 2019 | $21,499,000 | +22.4% | 163,487 | -2.0% | 0.17% | +16.8% |
| Q4 2018 | $17,558,000 | +9.1% | 166,793 | +1.0% | 0.15% | +14.6% |
| Q3 2018 | $16,094,000 | -15.6% | 165,197 | -13.7% | 0.13% | -2.3% |
| Q2 2018 | $19,073,000 | -3.5% | 191,528 | -1.7% | 0.13% | -5.7% |
| Q1 2018 | $19,773,000 | -2.1% | 194,811 | -2.2% | 0.14% | +4.4% |
| Q4 2017 | $20,200,000 | +5.6% | 199,247 | -4.4% | 0.14% | -2.2% |
| Q3 2017 | $19,136,000 | +5.4% | 208,437 | -4.7% | 0.14% | +1.5% |
| Q2 2017 | $18,162,000 | +0.7% | 218,747 | +0.5% | 0.14% | -0.7% |
| Q1 2017 | $18,038,000 | +0.4% | 217,569 | -1.5% | 0.14% | -3.5% |
| Q4 2016 | $17,967,000 | +0.2% | 220,842 | -3.5% | 0.14% | -7.8% |
| Q3 2016 | $17,925,000 | +6.9% | 228,869 | +10.8% | 0.15% | +6.2% |
| Q2 2016 | $16,773,000 | -15.3% | 206,564 | -1.8% | 0.14% | -18.1% |
| Q1 2016 | $19,801,000 | +7.4% | 210,382 | +0.9% | 0.18% | -2.2% |
| Q4 2015 | $18,444,000 | -0.8% | 208,414 | -4.5% | 0.18% | +2.8% |
| Q3 2015 | $18,597,000 | -51.7% | 218,249 | -51.4% | 0.18% | +6.7% |
| Q2 2015 | $38,464,000 | +94.3% | 449,414 | +92.7% | 0.16% | -1.8% |
| Q1 2015 | $19,800,000 | -46.9% | 233,221 | -46.4% | 0.17% | +4.3% |
| Q4 2014 | $37,294,000 | +119.3% | 435,130 | +94.4% | 0.16% | +7.3% |
| Q3 2014 | $17,006,000 | -9.5% | 223,825 | -6.2% | 0.15% | -6.2% |
| Q2 2014 | $18,791,000 | -12.6% | 238,691 | -16.8% | 0.16% | -3.0% |
| Q1 2014 | $21,507,000 | -1.2% | 286,751 | +1.7% | 0.16% | -2.4% |
| Q4 2013 | $21,771,000 | -3.4% | 282,012 | -13.3% | 0.17% | +7.6% |
| Q3 2013 | $22,537,000 | +10.7% | 325,116 | +1.1% | 0.16% | -5.4% |
| Q2 2013 | $20,350,000 | – | 321,484 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |